Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

638681

registered interest
date	18/11/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hepatitis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, pursuant to the Answer of 8 November 2016 to Question 51807, for what reasons access to the new treatments for hepatitis C that have been approved as cost-effective by NICE has been limited to 10,011 people in 2016-17.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	53772
answer	answer is ministerial correction date of answer 28/11/2016 answer text <p>The guidance issued by the National Institute for Health and Care Excellence (NICE) in relation to new direct acting antivirals for hepatitis C recommends that the decision to treat, and prescribing decisions, are made by multidisciplinary teams in the operational delivery networks put in place by NHS England. These prioritise treatment for people with the highest unmet clinical need.</p><p> </p><p>NHS England’s commitment to treat 10,000 patients in 2016/17, increasing to 12,500 in 2017/18, is in line with NICE’s estimate of activity included in the costing tools published to support implementation of the guidance.</p> answering member constituency Oxford West and Abingdon answering member printed Nicola Blackwood grouped question UIN 53767 question first answered 28/11/2016 15:17:26 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	4433 label Biography information for Thangam Debbonaire

638682

registered interest
date	18/11/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hepatitis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what discussions his Department has had with NHS England on its decision to limit the number of people able to access new hepatitis C treatments to 10,011; and on what basis that number was chosen.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	53767
answer	answer is ministerial correction date of answer 28/11/2016 answer text <p>The guidance issued by the National Institute for Health and Care Excellence (NICE) in relation to new direct acting antivirals for hepatitis C recommends that the decision to treat, and prescribing decisions, are made by multidisciplinary teams in the operational delivery networks put in place by NHS England. These prioritise treatment for people with the highest unmet clinical need.</p><p> </p><p>NHS England’s commitment to treat 10,000 patients in 2016/17, increasing to 12,500 in 2017/18, is in line with NICE’s estimate of activity included in the costing tools published to support implementation of the guidance.</p> answering member constituency Oxford West and Abingdon answering member printed Nicola Blackwood grouped question UIN 53772 question first answered 28/11/2016 15:17:25 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	4433 label Biography information for Thangam Debbonaire

638685

registered interest
date	18/11/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hepatitis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, with reference to the World Health Organisation's Global Health Sector Strategy on Viral Hepatitis, whether he plans to produce a national strategy for the elimination of hepatitis C by 2030.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	53796
answer	answer is ministerial correction date of answer 28/11/2016 answer text <p>The United Kingdom has a comprehensive surveillance system in place combining laboratory diagnoses data, risk/behaviour data, outcome data, statistical modelling and service evaluation to monitor the cascade of care, detect outbreaks, and generate burden estimates. The UK already has a comprehensive national programme of screening of blood donors and blood transfusions for blood-borne viruses, including hepatitis C, to ensure safe supplies – 100% of blood donors are screened with quality assured methods. There is national guidance and legislation around infection control in healthcare settings including a policy for healthcare workers to prevent nosocomial transmission of blood-borne viruses. Prevention efforts in minimising harm in people who inject drugs is focused on access to opiate substitution therapies and needle syringe exchange programmes, and disinfection tablets in prisons.</p><p>Public Health England has published hepatitis C metrics for the report “Hepatitis C in the UK 2016 report - Working towards its elimination as a major public health threat”. The report is available at the link below:</p><p><a href="https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/541317/Hepatitis_C_in_the_UK_2016_report.pdf" target="_blank">https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/541317/Hepatitis_C_in_the_UK_2016_report.pdf</a></p> answering member constituency Oxford West and Abingdon answering member printed Nicola Blackwood question first answered 28/11/2016 15:20:19 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	4433 label Biography information for Thangam Debbonaire

638757

registered interest
date	18/11/2016
answering body	Department for Work and Pensions
answering dept id	29
answering dept short name	Work and Pensions
answering dept sort name	Work and Pensions
hansard heading	Pensioners: British Nationals Abroad
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Work and Pensions, how many UK pensioners live in (a) other EU countries, (b) Commonwealth countries and (c) the rest of the world; and how many of those people have an address in Bristol West constituency as their most recent UK residence.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	53851
answer	answer is ministerial correction date of answer 24/11/2016 answer text <p>The table below shows the number of pensioners in receipt of the UK State Pension living in the country groupings requested. Please note that residents in Cyprus and Malta appear in both the European Union and Commonwealth totals.</p><p> </p><table><tbody><tr><td><p><strong>Country Group</strong></p></td><td><p><strong>Number of UK State Pensioners</strong></p></td></tr><tr><td><p>European Union (excluding UK)</p></td><td><p>474,130</p></td></tr><tr><td><p>Commonwealth (excluding UK)</p></td><td><p>565,770</p></td></tr><tr><td><p>Rest of the world</p></td><td><p>218,580</p></td></tr></tbody></table><p>Source: DWP Work and Pensions Longitudinal Study May 2016.</p><p>Figures are rounded to the nearest 10.</p><p>The information in relation to those who reside overseas and previously lived at an address in Bristol West constituency is not collated centrally and could only be provided at disproportionate cost.</p><p> </p> answering member constituency Watford answering member printed Richard Harrington question first answered 24/11/2016 13:47:49 answering member 4068 label Biography information for Lord Harrington of Watford
tabling member	4433 label Biography information for Thangam Debbonaire

638775

registered interest
date	18/11/2016
answering body	Department for International Trade
answering dept id	202
answering dept short name	International Trade
answering dept sort name	International Trade
hansard heading	Overseas Trade: Palestinians
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for International Trade, with reference to the Government's press release of 14 October 2016 on the visit to the Occupied Palestinian Territories of the UK trade envoy for that region, what further steps he plans to take in order to facilitate trade by (a) people in the Palestinian Business Women's Forum and (b) other Palestinian women.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	53731
answer	answer is ministerial correction date of answer 23/11/2016 answer text <p>The Prime Minister’s Trade Envoy to Occupied Palestinian Territories (OPT) Baroness Morris, visited the market in October. Following this there are plans to reactivate the Palestinian British Business Council to facilitate and develop trade links between the UK and the OPT including members of the Palestinian Business Women's Forum (PBWF).</p><p>The PBWF in Ramallah, with the UK government’s help, aims to host specialised speakers from the UK to educate forum members and other beneficiaries about the import and export regulations and the business environment in the UK for start-up businesses.</p><p>Further to this, the DFID-EU’s Palestinian Market Development Programme (PMDP) is a high performing programme which has helped 283 companies to develop new products and/or enter new markets. Approximately 50% of the companies assisted are women owned/managed companies.</p> answering member constituency Wyre Forest answering member printed Mark Garnier question first answered 23/11/2016 13:17:30 answering member 4074 label Biography information for Mark Garnier
tabling member	4433 label Biography information for Thangam Debbonaire